< Terug naar vorige pagina
Octrooi
Methods for diagnosing ovarian cancer
The invention relates to in vitro methods of distinguishing, in a patient diagnosed with an ovarian tumour, between a benign ovarian cyst and malignant ovarian cancer, based on determining in a blood sample the amount of at least NK cells, total myeloid cells, myeloid-derived suppressor cells (MDSC), monocytic myeloid derived suppressor cells (mMDSC), and PDL1 positive monocytic myeloid derived suppressor cells (mMDSC-PDL1). The invention further relates to kits comprising reagents for the detection of NK cells, myeloid-derived suppressor cells (MDSC), monocytic myeloid derived suppressor cells (mMDSC), and PDL1 positive monocytic myeloid derived suppressor cells (mMDSC-PDL1).
Octrooi-publicatienummer: WO2020193403
Jaar aanvraag: 2020
Jaar toekenning: 2021
Jaar van publicatie: 2020
Status: Aangevraagd
URI: link to Espacenet
Technologiedomeinen: Analyse van biologische materialen
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven